Small Cajal body-specific RNAs (scaRNA) are conserved small noncoding RNAs that guide post-transcriptional modification of spliceosomal RNA (snRNA), a key step for accurate spliceosome biogenesis and
Mucocutaneous disorders often present with oral manifestations, which are recurrent, and painful, and currently have no definitive management options. Corticosteroids are the first-line drugs to be ad
